Tag | Content |
---|
EnhancerAtlas ID | HS180-32481 |
Organism | Homo sapiens |
Tissue/cell | Small_intestine |
Coordinate | chr3:10235710-10237760 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
IRF1 | MA0050.2 | chr3:10236764-10236785 | AACAAGAAAAAGAAAGAGAAA | - | 6.03 | MEF2C | MA0497.1 | chr3:10236242-10236257 | TTCTATTTTTATTTC | - | 6.18 | ZNF263 | MA0528.1 | chr3:10237576-10237597 | TGAGGAGGGAGGGTGGAGGGA | + | 6.11 | ZNF263 | MA0528.1 | chr3:10237580-10237601 | GAGGGAGGGTGGAGGGAGAGA | + | 6.21 |
|
| Number of super-enhancer constituents: 26 | ID | Coordinate | Tissue/cell |
SE_01374 | chr3:10233588-10237950 | Adrenal_Gland | SE_02168 | chr3:10232890-10237812 | Aorta | SE_03544 | chr3:10235224-10237802 | Brain_Angular_Gyrus | SE_05284 | chr3:10230421-10238972 | Brain_Cingulate_Gyrus | SE_06271 | chr3:10230310-10239221 | Brain_Hippocampus_Middle | SE_07281 | chr3:10230345-10238980 | Brain_Hippocampus_Middle_150 | SE_08553 | chr3:10230394-10238941 | Brain_Inferior_Temporal_Lobe | SE_10483 | chr3:10232905-10238935 | CD19_Primary | SE_11117 | chr3:10230364-10244148 | CD20 | SE_12182 | chr3:10233126-10238474 | CD3 | SE_18222 | chr3:10230393-10242416 | CD4p_CD25-_CD45ROp_Memory | SE_18887 | chr3:10230456-10239154 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19527 | chr3:10232850-10237954 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20302 | chr3:10232846-10239394 | CD56 | SE_22972 | chr3:10232902-10238955 | CD8_primiary | SE_27300 | chr3:10232887-10237905 | Esophagus | SE_35045 | chr3:10230429-10236765 | HeLa | SE_35045 | chr3:10236934-10238116 | HeLa | SE_36305 | chr3:10230416-10237861 | HMEC | SE_38379 | chr3:10230299-10236156 | HUVEC | SE_46480 | chr3:10232852-10239588 | Osteoblasts | SE_55870 | chr3:10232869-10239613 | u87 | SE_58615 | chr3:10208482-10269048 | Ly1 | SE_62498 | chr3:10211834-10316085 | Tonsil | SE_64685 | chr3:10232624-10237158 | NHEK | SE_67695 | chr3:10232869-10239613 | u87 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr3 | 10237363 | 10237636 | chr3 | 10237175 | 10237307 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH03I010188 | chr3 | 10230458 | 10242599 |
|
Enhancer Sequence | TCTGGCAGAA CTGAAGGAGG GTGGCTGTTT GCACAGTGTT GTGGGCCCCT GCCCTGGGCC 60 AGCCACTTCA CATTTGTCAT CATGGAGCCC TGGGACGGCC CTGGGAGGTG TGGGGTTATT 120 ATTCTGATTC CACAGGAGAG GCGCATGAAG CTCAGAGGGT TAGGAGGTCT GTGCCTGGGC 180 GTGAAGCTGG AATCGCAGAG CTTGGGTCTG GCTCAAGCCA GAGCCGACGC TTCCCCACGC 240 TTACTCTTGT GATCCTAGTT CTACTCTTTG ATCACAGTCT GTGTTTTTGG ATCTCATGAT 300 CCTGCAGAAT CAACTTTATG TGTGGAATTC TCTTGAGAAT TTAATCCTGG GAGGAAAGAG 360 TGCTGTCTTG GAAGCCTGAG GCTGCCCCTG TCTATCTGTG ATAAGAAGTC CGTGAGCAGC 420 TCACTCCTGA GCCTTGGCCT TGGCAGATAG GAAGCTCAGT GCGAGAGTTA AAGCTTGTCA 480 CAGCCCTTTC TTGTAGGCAT TTGGCCTCCT TTGCCTCATC CTGCCTTTGG TGTTCTATTT 540 TTATTTCACT AGCTCTCTGG TGTGCCAGCC TGAATGAGTG GGCGTTGCGT CTTTCTAGCT 600 AGCAGGGAGC AGGTTTGGAG GGATGAGGAC AGAGGCCATT TTCTCCATCT TCATGTTTGG 660 ACAGTGGGAC AGGCATGCAT GGGCCTGCCT GTCCACCCAG CTCAGACCAT GCCGGCAGCT 720 CCAGGGTGGA GATGAGGGCG GTTCATGTTT ATACGCACCA TTTATTGCTT GCATTTTAAA 780 GACATCTAAA AACTCAAAGC TTGAGAAGAT GGGGGTTTCA CAGGAAACCA GAACTTCTTG 840 TTGGGGCTGA CATGGGGCTC TGTTGGCTTA CATCCGTGGC TGGTGTGACC TGGTGCCTCT 900 TGTGTGGGAG GGTGGATGTT AGCCCCAAGT GTGCTGACAG GTCTGGTCAC AGGTAGCCCT 960 GCCGACACCG CCCCTCCCCA TCTGTTCCTC ACTCCTGCTC ACTTCCAAAT GCCCTGTGGT 1020 GCCAGGTGGG GCCACCGCAT GTCACTGCAG AAGGAACAAG AAAAAGAAAG AGAAAAGCTG 1080 GACTCTCTTT AGGATGAAAA CATAATGACA TTTTTTATCT TCCCCACGGG TGGAGCCCAC 1140 AGAGGTCGGC CACAAATGGG TTGGTGGCCT TGATGTTCCT GCCAAATGTG TTTTGACAGA 1200 GAGGCAAAGA TTTGTGCTGA ACAAAACATT ACCCTGAATA GGACACTGGA CTGGGAGCAG 1260 TGGCTCAGGC CTGTAATCCC AGCACTTTGG GAGGACAAGG TGGGAGGATC ACTGGGGCCT 1320 AGGAGTTTGA GCCCAGGCTG GGCAACATAG TGAGATGCTG TCTCTACACA AAATTAAAAA 1380 TTAGCTGGGC GTGGTGTTGC CTGTAATCCC AGCGGCATGG GAGGCTAAGA GAGGAGGATA 1440 GCTTGAGCTC AGGAGTTTGA GGCTGCAGTG AGCTGTGATC ACACCACTGC ATAGCCTGGG 1500 TGACAGAGCA ACACCCTGTC TCAAAAAAAA AAAAAAGGAA CAGGACACTG AAGTTAAGTA 1560 AGGCTGTAAG TATCACCCTC ATCCCCGTTT TACTGTGATG AGAACAATGA GGCTCAGCCA 1620 GGCAGGCCTC CGACAAGGAG AAGGTGCCTC ATTTGCTGGG ATCATGGGCG GTTCTGGGTG 1680 TAGGTGAGAC CTTTAGGGAG CATTTTATAC TGTTGCGGGC CTGGCCTCTG CAGGAGGTCA 1740 CTGTTGGGAA GTGACTTCAG CGAGCCCAGC CGGCCCTGAG CCAGGGGAGC CACTGCTGCC 1800 CTTTTGACAC AGATGTCACA AGGATGACAA GCCTTTCCAG GAGCATAAGC CCCACTTGAG 1860 GCAGTTTGAG GAGGGAGGGT GGAGGGAGAG AGGCAGTCTC TCCCTGCCAG AGAGGGGAGG 1920 CTGGGAAAGA TGAGGACTGG GAGTGGCGGG GGGTAGCCTT CCAAGGGAGC ACAGGCAGAG 1980 CTTTCACTTC TGTGCACCCT GGGAGCGACA GCTCTGTTCC AGACCCGTGC TTGAATCAGC 2040 ACTCACCCCG 2050
|